NICE Topic Selection

Executive Summary

Unlike some HTA bodies, e.g. the Scottish Medicines Consortium (SMC), England’s National Institute for Health and Care Excellence (NICE) does not appraise every new medicine that comes to market in England but this is expected to change under the 2019 Voluntary Scheme.

The Topic Selection programme considers new technologies for routing to either Technology Appraisal (TA) or Highly Specialised Technologies (HST) assessment.